Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous…
Reason Crystallization; identified as Buprenorphine free base
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.
Buprenorphine HCI Injection, 0.3 mg/mL, 1 mL Single Dose Vial (NDC 42023-179-01), packaged in 1 mL x 5 Single Dose Vials per carton (NDC 42023-179-05), Rx Only, Distributed by: Par Pharmaceuticals Companies, Inc., Spring Valley, NY 10977.
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Crystallization; identified as Buprenorphine free base
Reason Crystallization; identified as Buprenorphine free base
Reason Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Reason CGMP Deviations
Reason Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.